The role of vascular endothelial growth inhibitor in wound healing

International Wound Journal

Volumn 4, Issue 1, 2007, Pages 55-64

  Conway, Kevin P ^a,b   Price, Patricia ^a   Harding, Keith G ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Vascular endothelial growth inhibitor; Wound healing

Indexed keywords

SCATTER FACTOR; VASCULOTROPIN INHIBITOR;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CHRONIC WOUND; CONTROLLED STUDY; DERMIS; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MICROTUBULE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; WOUND; WOUND HEALING;

EID: 34147101736     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2006.00295.x     Document Type: Article

References (13)

1. Zhai Y, Ni J, Jiang GW, Lu J, Xing L, Lincoln C, Carter KC, Janat F, Kozak D, Xu S, Rojas L, Aggarwal BB, Ruben S, Li LY, Gentz R, Yu GL. VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASEB J 1999;13:181-9.
2. Haridas V, Shrivastava A, Su J, Yu GL, Ni J, Liu D, Chen SF, Ni Y, Ruben SM, Gentz R, Aggarwal BB. VEGI, a new member of the TNF family activates nuclear factor-kappa B and c-Jun N-terminal kinase and modulates cell growth. Oncogene 1999;18:6496-504.
3. Tan KB, Harrop J, Reddy M, Young P, Emery J, Moore G, Truneh A. Characterization of a novel TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in haematopoietic and non-haematopoietic cells. Gene 1997;204:35-46.
4. Zhai Y, Yu J, Iruela-Arispe L, Huang WQ, Wang Z, Hayes AJ, Lu J, Jiang G, Rojas L, Lippman ME, Ni J, Yu GL, Li LY. Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEGI, a novel cytokine of the TNF superfamily. Int J Cancer 1999;82:131-6.
5. Parr C, Gan CH, Watkins G, Jiang WG. Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients. Angiogenesis 2006;9:73-81.
6. Davies G, Jiang WG, Mason MD. Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells. J Urol 2000;163:985-92.
7. Kuniyasu A, Kawano S, Hirayama Y, Ji YH, Xu K, Ohkura M, Furukawa K, Ohizumi Y, Hiraoka M, Nakayama H. A new scorpion toxin (BmK-PL) stimulates Ca2+-release channel activity of the skeletal-muscle ryanodine receptor by an indirect mechanism. Biochem J 1999;339(pt 2):343-50.
8. Jiang WG, Watkins G, Lane J, Cunnick GH, Douglas-Jones A, Mokbel K, Mansel RE. Prognostic value of Rho GTPases and Rho guanine nucleotide dissociation inhibitors in human breast cancers. Clin Cancer Res 2003;9:6432-40.
9. Cunnick GH, Jiang WG, Gomez KF, Mansel RE. Lymphangiogenesis quantification using quantitative PCR and breast cancer as a model. Biochem Biophys Res Commun 2001;288:1043-6.
10. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mokbel K, Mansel RE. Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy. Clin Cancer Res 2005;11:6012-19.
11. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mansel RE. Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells. Int J Mol Med 2006;17:583-90.
12. Trochon V, Mabilat C, Bertrand P, Legrand Y, Smadja-Joffe F, Soria C, Delpech B, Lu H. Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int J Cancer 1996;66:664-8.
13. Xiao Q, Hsu CY, Chen H, Ma X, Xu J, Lee JM. Characterization of cis-regulatory elements of the vascular endothelial growth inhibitor gene promoter. Biochem J 2005;388:913-20.